APA

Tontsch-Grunt U., Rudolph D., Waizenegger I., Baum A., Gerlach D., Engelhardt H., Wurm M., Savarese F., Schweifer N. & Kraut N. (20190506). Synergistic activity of BET inhibitor BI 894999 with PLK inhibitor volasertib in AML in vitro and in vivo. : Cancer letters.

Chicago

Tontsch-Grunt Ulrike, Rudolph Dorothea, Waizenegger Irene, Baum Anke, Gerlach Daniel, Engelhardt Harald, Wurm Melanie, Savarese Fabio, Schweifer Norbert and Kraut Norbert. 20190506. Synergistic activity of BET inhibitor BI 894999 with PLK inhibitor volasertib in AML in vitro and in vivo. : Cancer letters.

Harvard

Tontsch-Grunt U., Rudolph D., Waizenegger I., Baum A., Gerlach D., Engelhardt H., Wurm M., Savarese F., Schweifer N. and Kraut N. (20190506). Synergistic activity of BET inhibitor BI 894999 with PLK inhibitor volasertib in AML in vitro and in vivo. : Cancer letters.

MLA

Tontsch-Grunt Ulrike, Rudolph Dorothea, Waizenegger Irene, Baum Anke, Gerlach Daniel, Engelhardt Harald, Wurm Melanie, Savarese Fabio, Schweifer Norbert and Kraut Norbert. Synergistic activity of BET inhibitor BI 894999 with PLK inhibitor volasertib in AML in vitro and in vivo. : Cancer letters. 20190506.